Transcriptomics

Dataset Information

0

Nuclear MTHFD2 secures centromere methylation, chromosome stability and correct mitosis progression [RNA-seq]


ABSTRACT: Subcellular compartmentalization of metabolic enzymes may elicit specific cellular functions by establishing a unique metabolic environment. Indeed, the nuclear translocation of certain metabolic enzymes is required for epigenetic regulation and gene expression control. Here, we reveal that, in cancer cells, the mitochondrial enzyme methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) localizes in the nucleus during the G2-M phase of the cell cycle to secure mitosis progression. Nuclear MTHFD2 interacts with proteins involved in mitosis regulation and centromere stability, including the methyltransferases KMT5A and DNMT3B. Loss of MTHFD2 induces centromere overexpression and severe methylation defects, and impedes correct mitosis completion. As a consequence, MTHFD2 deficient cells accumulate chromosomal aberrations arising from chromosome congression and segregation defects. Blocking the catalytic nuclear function of MTHFD2 recapitulates the phenotype observed in MTHFD2 deficient cells, attributing to nuclear MTHFD2 an enzymatic active role in controlling mitosis. Our discovery uncovers a nuclear moonlighting role for the cancer target MTHFD2, and emphasizes that cancer metabolism rewiring may encompass the relocation of metabolic enzymes to alternative subcellular compartments.

ORGANISM(S): Homo sapiens

PROVIDER: GSE230750 | GEO | 2024/07/26

REPOSITORIES: GEO

Similar Datasets

2024-07-26 | GSE232307 | GEO
2018-06-19 | GSE100261 | GEO
2014-09-27 | E-GEOD-61806 | biostudies-arrayexpress
2014-09-27 | GSE61806 | GEO
2023-11-20 | PXD046003 | Pride
2014-10-07 | MSV000078890 | MassIVE
2013-04-18 | E-GEOD-46142 | biostudies-arrayexpress
2018-10-11 | GSE100643 | GEO
2020-02-28 | PXD014257 | Pride
2023-05-26 | GSE233350 | GEO